European Ulcerative Colitis Patients Have Low Medication Adherence, Tillotts Pharma Survey Shows

European Ulcerative Colitis Patients Have Low Medication Adherence, Tillotts Pharma Survey Shows
Tillotts Pharma AG LogoMore than 90% of the patients who suffer from ulcerative colitis in Europe have either low or medium adherence to their medication, which increases patients' probability of suffering relapses up to five times. These conclusions are from a survey recently conducted and reported by the company Tillotts Pharma and presented at the 10th Congress of the European Crohn's and Colitis Organization (ECCO) in Barcelona, Spain. The survey was conducted by the company to understand how European patients are dealing with ulcerative colitis, one of the two types of inflammatory bowel disease (IBD) estimated to affect about three million people across Europe. The study included 507 UC patients, as well as 27 healthcare professionals located in the UK, Spain, Sweden, Norway, Finland, Denmark, Ireland and the Czech Republic. Within the survey, about nine in every 10 patients reported to have moderate or low medication adherence, and the majority of the participants said the disease n
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *